Cargando…
Depolarization Controls TRAIL-Sensitization and Tumor-Selective Killing of Cancer Cells: Crosstalk with ROS
Conventional genotoxic anti-cancer drugs target the proliferative advantage of tumor cells over normal cells. This kind of approach lacks the selectivity of treatment to cancer cells, because most of the targeted pathways are essential for the survival of normal cells. As a result, traditional cance...
Autores principales: | Suzuki-Karasaki, Yoshihiro, Suzuki-Karasaki, Miki, Uchida, Mayumi, Ochiai, Toyoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038927/ https://www.ncbi.nlm.nih.gov/pubmed/24910845 http://dx.doi.org/10.3389/fonc.2014.00128 |
Ejemplares similares
-
Aspirin Induces Mitochondrial Ca(2+) Remodeling in Tumor Cells via ROS‒Depolarization‒Voltage-Gated Ca(2+) Entry
por: Fujikawa, Itsuho, et al.
Publicado: (2020) -
Depolarization potentiates TRAIL-induced apoptosis in human melanoma cells: Role for ATP-sensitive K(+) channels and endoplasmic reticulum stress
por: SUZUKI, YOSHIHIRO, et al.
Publicado: (2012) -
Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells: role of plasma membrane depolarization
por: Suzuki-Karasaki, Yoshihiro, et al.
Publicado: (2015) -
Autophagy inhibitors regulate TRAIL sensitivity in human malignant cells by targeting the mitochondrial network and calcium dynamics
por: Onoe-Takahashi, Asuka, et al.
Publicado: (2019) -
Plasma-stimulated medium kills TRAIL-resistant human malignant cells by promoting caspase-independent cell death via membrane potential and calcium dynamics modulation
por: Tokunaga, Tomohiko, et al.
Publicado: (2018)